Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,020

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

July 28, 2025

Study Completion Date

August 12, 2025

Conditions
Hemorrhagic ShockTraumatic Injury
Interventions
BIOLOGICAL

low titer whole blood

low titer whole blood, group O kept to either 21 days or 35 days based upon which preservation process is employed at each respective participating site

BIOLOGICAL

Standard Care

crystalloid infusion or blood component transfusion resuscitation

Trial Locations (10)

15213

University of Pittsburgh, Pittsburgh

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical Center, Nashville

37920

University of Tennessee Medical Center, Knoxville

39216

University of Mississippi Medical Center (UMMC), Jackson

40292

University of Louisville, Louisville

44109

Metrohealth Systems, Cleveland

45267

University of Cincinatti, Cincinnati

77030

University of Texas Health Science Center at Houston, Houston

98104

University of Washington, Seattle

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Jason Sperry

OTHER